IRIS UniCatt

Sgalla, Giacomo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.235
AS - Asia 1.844
EU - Europa 1.232
SA - Sud America 433
Continente sconosciuto - Info sul continente non disponibili 100
AF - Africa 63
OC - Oceania 4
Totale 5.911
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.151
SG - Singapore 806
CN - Cina 364
BR - Brasile 361
IT - Italia 361
VN - Vietnam 216
SE - Svezia 213
DE - Germania 133
FR - Francia 125
BD - Bangladesh 120
GB - Regno Unito 76
IE - Irlanda 67
PL - Polonia 62
ID - Indonesia 55
HK - Hong Kong 51
RU - Federazione Russa 50
JP - Giappone 49
IN - India 43
CA - Canada 34
KR - Corea 30
FI - Finlandia 29
MX - Messico 27
AR - Argentina 25
AT - Austria 22
IQ - Iraq 16
UA - Ucraina 15
ZA - Sudafrica 15
SA - Arabia Saudita 14
BE - Belgio 13
NL - Olanda 13
EC - Ecuador 12
ES - Italia 12
MA - Marocco 12
TR - Turchia 12
IR - Iran 11
VE - Venezuela 10
PK - Pakistan 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
CO - Colombia 8
EG - Egitto 8
KE - Kenya 8
PY - Paraguay 8
LT - Lituania 7
PH - Filippine 7
UZ - Uzbekistan 7
CR - Costa Rica 6
TN - Tunisia 6
CI - Costa d'Avorio 5
RO - Romania 5
TT - Trinidad e Tobago 5
CZ - Repubblica Ceca 4
TW - Taiwan 4
AL - Albania 3
AU - Australia 3
AZ - Azerbaigian 3
DZ - Algeria 3
ET - Etiopia 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
BO - Bolivia 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
LV - Lettonia 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
CU - Cuba 1
DM - Dominica 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
Totale 5.811
Salva come PNG Salva come JPEG
Città #
Singapore 448
San Jose 281
Ashburn 238
Chandler 208
Beijing 100
Rome 94
The Dalles 84
Ho Chi Minh City 73
Milan 68
Dublin 67
New York 64
Lauterbourg 53
Los Angeles 53
Warsaw 52
Hefei 50
Tokyo 47
Hong Kong 46
Jakarta 46
Hanoi 45
Frankfurt am Main 37
San Mateo 32
São Paulo 32
St Louis 31
Boston 30
Princeton 29
Fairfield 28
Bar Harbor 27
Dallas 26
Moscow 26
Munich 24
Orem 24
Ann Arbor 22
Houston 22
Nuremberg 21
Santa Clara 21
Wilmington 20
Chicago 19
North Bergen 19
Seoul 19
Council Bluffs 18
Helsinki 17
Kent 17
London 17
Denver 16
Phoenix 16
Woodbridge 16
Mexico City 15
Düsseldorf 14
Tukwila 14
Atlanta 13
Boardman 13
Brooklyn 13
Buffalo 13
Stockholm 13
Rio de Janeiro 12
Vienna 12
Shanghai 11
Brussels 10
Chennai 10
Naples 10
Bremen 9
Da Nang 9
Jacksonville 9
Kish 9
Montreal 9
Paris 9
Poplar 9
Portsmouth 9
Pune 9
Amsterdam 8
Augusta 8
Belo Horizonte 8
Brasília 8
Casablanca 8
Curitiba 8
Haiphong 8
San Francisco 8
Toronto 8
Catania 7
Charlotte 7
Florence 7
Guangzhou 7
Guayaquil 7
Johannesburg 7
Las Vegas 7
Marseille 7
Nairobi 7
Turku 7
Washington 7
Ankara 6
Baghdad 6
Fortaleza 6
Guarulhos 6
Hải Dương 6
Norwalk 6
Philadelphia 6
San José 6
Tashkent 6
Abidjan 5
Asunción 5
Totale 3.210
Salva come PNG Salva come JPEG
Nome #
Residual respiratory impairment after COVID-19 pneumonia 202
Residual respiratory impairment after COVID-19 pneumonia 187
The management of Familial Pulmonary Fibrosis in different medical settings: Where does that leave us? An Italian nationwide survey 163
Usual Interstitial Pneumonia Pattern and Mycobacteria Lung Diseases: A Case Series 157
Mediastinal lymph node enlargement in idiopathic pulmonary fibrosis: Relationships with disease progression and pulmonary function trends 154
Experimental autotaxin inhibitors for the treatment of idiopathic pulmonary fibrosis 145
Case of a 33-Year-Old Woman With Hemoptysis and Migrant Nodular Cavitary Lesions 144
Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study 139
Telemedicine-enabled, Hotel-based Management of Patients with COVID-19: A Single-Center Feasibility Study 135
Reliability of crackles in fibrotic interstitial lung disease: a prospective, longitudinal study 133
Promising advances in treatments for the management of idiopathic pulmonary fibrosis 132
Digital lung auscultation: Will early diagnosis of fibrotic interstitial lung disease become a reality? 130
Antibody-based therapies for idiopathic pulmonary fibrosis 128
Acute Respiratory Distress Syndrome and Lung Fibrosis Complicating Surgery in a Patient with Crohn's Disease 125
A randomized trial of pamrevlumab in patients with COVID-19 pneumonia 124
Antibody-based therapies for idiopathic pulmonary fibrosis 123
Impact of chest imaging quality on the diagnosis of the usual interstitial pneumonia pattern: a hub and spoke study 123
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis 123
BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF) 121
Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approach 119
Pamrevlumab for the treatment of idiopathic pulmonary fibrosis 118
Progressive Fibrosing Interstitial Lung Disease A Proposed Integrated Algorithm for Management 113
Home spirometry to assess efficacy of pirfenidone in progressive unclassifiable interstitial lung disease: better the devil you know than the devil you don't 113
Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis 110
Advances with pharmacotherapy for the treatment of interstitial lung disease 109
Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement 108
Effectiveness of Nintedanib in Progressive Pulmonary Fibrosis Assessed by Progression Criteria: An Italian, Observational, Multicenter Study 107
Fibrotic Hypersensitivity Pneumonitis: Diagnosis and Management 107
An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyond 102
Early diagnosis of idiopathic pulmonary fibrosis: Closer to the goal? 100
Perception of the role of Telemedicine in Interstitial Lung Diseases: ­Findings from Società Italiana di Pneumologia/ Italian Respiratory ­Society (SIP-IRS) survey 98
Role of Stenotrophomonas maltophilia isolation in patients with non CF bronchiectasis 98
Restless legs syndrome: A new comorbidity in idiopathic pulmonary fibrosis 98
An updated safety review of the drug treatments for idiopathic pulmonary fibrosis 98
Emerging drugs for the treatment of idiopathic pulmonary fibrosis: 2020 phase II clinical trials 97
Automated system for diagnosing pulmonary fibrosis using crackle analysis in recorded lung sounds based on iterative envelope mean fractal dimension filter 96
X-ray Micro-Computed Tomography for Nondestructive Three-Dimensional (3D) X-ray Histology 95
Monitoring small airway dysfunction in connective tissue disease-related interstitial lung disease: a retrospective and prospective study 95
A Simple Ratio in a Complex Disease: Exploring the Neutrophil-to-Lymphocyte Ratio in Idiopathic Pulmonary Fibrosis 95
An up-to-date review of approved and emerging antibody therapies for idiopathic pulmonary fibrosis 91
Phase three clinical trials in idiopathic pulmonary fibrosis 87
“Velcro-type” crackles predict specific radiologic features of fibrotic interstitial lung disease 84
Reply to: Huang and Wei, Kang et al., and Ehteshami-Afshar and Raj 83
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy 72
Quantitative analysis of lung sounds for monitoring idiopathic pulmonary fibrosis: a prospective pilot study 72
The Shorter, the Better: Can We Improve Efficiency of Idiopathic Pulmonary Fibrosis Trials? 72
Do randomized clinical trials always provide certain results? 70
Better be an Agnostic than a Believer (at Least in Pulmonary Fibrosis) 69
DEEP-LEARNING ANALYSIS OF HRCT IMAGES PREDICTS PULMONARY PROGRESSION AND MORTALITY IN SYSTEMIC SCLEROSIS RELATED INTERSTITIAL LUNG DISEASE 66
Update in pulmonary fibrosis 2018 61
COVID-related fibrosis: insights into potential drug targets 60
DEEP-LEARNING ANALYSIS OF HRCT IMAGES PREDICTS PULMONARY PROGRESSION AND MORTALITY IN SYSTEMIC SCLEROSIS RELATED INTERSTITIAL LUNG DISEASE 59
Pharmacological treatment of idiopathic pulmonary fibrosis: Time to step out of the comfort zone? 53
Long-term treatment with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a comparative, real-world cohort study 51
Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosis 50
Impact of Chest CT Quality on the Diagnosis of Usual Interstitial Pneumonia (UIP) Pattern: A Hub and Spoke Study 28
null 19
Totale 5.911
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.515
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022238 0 0 4 27 9 11 2 55 15 8 57 50
2022/2023558 60 69 41 87 48 54 18 42 77 34 18 10
2023/2024389 13 82 13 23 16 31 25 14 19 45 55 53
2024/20251.044 36 12 92 54 84 35 53 49 126 121 238 144
2025/20263.156 369 185 184 395 519 134 482 137 170 228 184 169
2026/2027298 121 136 41 0 0 0 0 0 0 0 0 0
Totale 5.911